Initially developed for type 2 diabetes, GLP-1RAs have demonstrated robust weight loss in randomized controlled trials and real-world settings, leading to their repositioning as cornerstone obesity treatments ( Human metabolic studies consistently show that reductions in energy intake account for most of the weight loss observed during GLP-1RA therapy, whereas increases in resting energy expenditure are modest or absent ( Beyond total weight loss, the quality of weight loss has become an increasingly important clinical concern
Intriguingly, physiological activation of the androgen receptor has been demonstrated to promote ROS production [23]
& Huang, Y
This observation coincides with in vitro findings by Rebouche et al
Chronic tennis elbow often presents with pain that has been present for six months or longer, structural changes visible on ultrasound or MRI, decreased grip strength, pain at rest in addition to activity, and previous failed treatments
So he talked to a doctor and decided to try BPC-157